P3 Health Partners (PIII)
(Delayed Data from NSDQ)
$0.39 USD
-0.04 (-9.44%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $0.39 0.00 (0.15%) 5:30 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
P3 Health Partners Inc. (PIII) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.47 | $5.00 | $0.90 | 706.98% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for P3 Health Partners Inc. comes to $3.47. The forecasts range from a low of $0.90 to a high of $5.00. The average price target represents an increase of 706.98% from the last closing price of $0.43.
Analyst Price Targets (3 )
Broker Rating
P3 Health Partners Inc. currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, two are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/7/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
4/1/2024 | BTIG | David M Larsen | Strong Buy | Hold |
3/14/2024 | Lake Street Capital Markets | Brooks G O'Neil | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 4 |
Average Target Price | $3.47 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 67 of 253 |
Current Quarter EPS Est: | -0.03 |
PIII FAQs
P3 Health Partners Inc. (PIII) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for P3 Health Partners Inc. (PIII) is $3.47. The current on short-term price targets is based on 1 reports.
The forecasts for P3 Health Partners Inc. (PIII) range from a low of $.901 to a high of $5. The average price target represents a increase of $706.98 from the last closing price of $.43.
The current UPSIDE for P3 Health Partners Inc. (PIII) is 706.98%
Based on short-term price targets offered by three analysts, the average price target for P3 Health Partners Inc. comes to $3.47. The forecasts range from a low of $0.90 to a high of $5.00. The average price target represents an increase of 706.98% from the last closing price of $0.43.